Vascular Calcification Induced by Chronic Kidney Disease Is Mediated by an Increase of 1α-Hydroxylase Expression in Vascular Smooth Muscle Cells

Abstract

Vascular calcification (VC) is a complication of chronic kidney disease that predicts morbidity and mortality. Uremic serum promotes VC, but the mechanism involved is unknown. A role for 1,25(OH) D in VC has been proposed, but the mechanism is unclear because both low and high levels have been shown to increase it. In this work we investigate the role of 1,25(OH) D produced in vascular smooth muscle cells (VSMCs) in VC. Rats with subtotal nephrectomy and kidney recipient patients showed increased arterial expression of 1α-hydroxylase in vivo. VSMCs exposed in vitro to serum obtained from uremic rats also showed increased 1α-hydroxylase expression. Those increases were parallel to an increase in VC. After 6 days with high phosphate media, VSMCs overexpressing 1α-hydroxylase show significantly higher calcium content and RUNX2 expression than control cells. 1α-hydroxylase null mice (KO) with subtotal nephrectomy and treated with calcitriol (400 ng/kg) for 2 weeks showed significantly lower levels of vascular calcium content, Alizarin red staining, and RUNX2 expression than wild-type (WT) littermates. Serum calcium, phosphorus, blood urea nitrogen (BUN), PTH, and 1,25(OH) D levels were similar in both calcitriol-treated groups. In vitro, WT VSMCs treated with uremic serum also showed a significant increase in 1α-hydroxylase expression and higher calcification that was not observed in KO cells. We conclude that local activation of 1α-hydroxylase in the artery mediates VC observed in uremia. © 2016 American Society for Bone and Mineral Research.

MicroRNA‑24‑3p inhibition prevents cell growth of vascular smooth muscle cells by targeting Bcl‑2‑like protein 11

“…VSMCs are the main cell type in blood vessels and, abnormal proliferation and apoptosis of VSMCs may result in the rapid development of disease (25,26). Recently, growing evidence has identified miRNAs as new biomarkers for a number of cardiovascular diseases (27,28).…”

Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase

“…[31] Furthermore, a recent paper from our laboratory has shown that the upregulation of local CYP27B1 in the vascular smooth muscle cells is of paramount importance in the genesis of uremic vascular calcification. [17] Thus, in KO animals the absence of CYP27B1 blocks the increase in vascular calcification. However, in WT animals the administration of 25(OH)D 3 could exacerbate the pro-calcificant effects of uremia by increasing the substrate for local production of 1,25(OH) 2 D 3 in the artery.…”

“…[17] Briefly, the parenchyma of the left kidney was reduced 50%. The kidney was exposed, decapsulated and carefully cauterized, reducing the parenchyma of the upper and the lower pole.…”

Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis

“…Real-time PCR with gene-specific TaqMan probes was performed with a CFX Real-Time PCR detection system (Bio-Rad Laboratories, Madrid, Spain) using TaqMan Universal PCR Master Mix, No AmpErase UNG. Forty cycles at 95°C for 15 s and 60°C for 1 min were performed 32,[55][56][57] . Relative mRNA levels were calculated by standard formulae (ΔΔCt method) using GAPDH or TBP as an endogenous control.…”